Maphar - A Sanofi company
Patient safety Print

Ensuring patient safety is the primary focus of our quality and pharmacovigilance teams. Our approach involves guaranteeing the quality of each phase of the product's life cycle, from the earliest steps of development to the distribution of products to sales channels.

To meet this challenge, our quality approach is designed to ensure we provide safe and effective products that are developed, manufactured, distributed, and marketed in compliance with regulatory requirements worldwide.

If you are a healthcare professional, a patient and you want to notify adverse events of a product please contact:

E-MAIL : This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Tel : 06 61 57 44 00
Fax : 05 22 34 79 84

You can also contact CENTRE NATIONAL DE PHARMACOVIGILANCE

EMERGENCY CALL : 05 37 68 64 64 - OR N° ECO 0801 000 180
Fax : 05 37 77 71 79
www.capm.ma

Sitemap Legal mentions Sanofi Morocco Sanofi Group .
Realisation - 3WMEDIA -